⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2398119 | 0.71 | — | — | |
| SCHEMBL21630548 | 0.69 | — | — | |
| SCHEMBL2357161 | 0.65 | — | — | |
| SCHEMBL29103257 | 0.62 | — | — | |
| SCHEMBL26112668 | 0.62 | — | — | |
| SCHEMBL9578382 | 0.61 | — | — | |
| SCHEMBL26292 | 0.60 | — | — | |
| SCHEMBL1875110 | 0.59 | — | — | |
| SCHEMBL3150886 | 0.59 | — | — | |
| SCHEMBL8466052 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114702615-A | Supported metallocenes, catalysts containing same, their preparation and use | 中国石油化工股份有限公司 | 2022-07-05 | — | — | CN | claimed |
| US-20150051179-A1 | NOVEL STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS | TOKAI PHARMACEUTICALS, INC. | 2015-02-19 | — | — | US | claimed |
| EP-1858879-B1 | 1,3-DIARYL SUBSTITUTED UREAS AS MODULATORS OF KINASE ACTIVITY | GILEAD CONNECTICUT INC (US) | 2012-06-06 | — | — | EP | claimed |
| US-20110312924-A1 | NOVEL STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS | TOKAI PHARMACEUTICALS, INC. (US) | 2011-12-22 | — | — | US | claimed |
| WO-2010091303-A1 | NOVEL STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS | TOKAI PHARMACEUTICALS (US) | 2010-08-12 | — | — | WO | claimed |
| EP-0680972-B1 | Trifluoromethylketone peptide derivatives, process for their preparation and pharmaceutical compositions comprising them | ADIR (FR) | 2000-03-08 | — | — | EP | claimed |
| US-5567804-A | HUMAN LEUCOCYTE ELASTASE INHIBITOR; ANTIOXIDANT | ADIR ET COMPAGNIE (FR) | 1996-10-22 | — | — | US | claimed |
| US-5565429-A | HUMAN LEUCOCYTE ELASTASE INHIBITORS; EMPHYSEMA; ANTIARTHRITIC AGENTS; RHEUMATIC DISEASES | ADIR ET COMPAGNIE (FR) | 1996-10-15 | — | — | US | claimed |
| EP-0680972-A1 | Trifluoromethylketone peptide derivatives, process for their preparation and pharmaceutical compositions comprising them | ADIR ET COMPAGNIE (FR) | 1995-11-08 | — | — | EP | claimed |
| US-5190923-A | For treatment of neurological disorders such as cognitive disorders | ADIR ET COMPAGNIE (FR) | 1993-03-02 | — | — | US | claimed |
| EP-0217688-B1 | PEPTIDE DERIVATIVES WITH A LACTONIC OR CYCLOAMIDIC STRUCTURE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ADIR ET COMPAGNIE (FR) | 1990-09-26 | — | — | EP | claimed |
| US-4725581-A | NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS | ADIR ET COMPAGNIE (FR) | 1988-02-16 | — | — | US | claimed |
| US-4713459-A | TRANSFERRING OXYGEN FOR HEMORRHAGE VICTIMS, PRESERVING ORGANS FOR SURGERY | THE GREEN CROSS CORPORATION (JP) | 1987-12-15 | — | — | US | claimed |
| EP-0217688-A1 | Peptide derivatives with a lactonic or cycloamidic structure, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1987-04-08 | — | — | EP | claimed |
| EP-4199925-B1 | CYCLOPENTAPYRROLE OREXIN RECEPTOR AGONISTS | MERCK SHARP & DOHME LLC (US) | 2026-05-20 | — | — | EP | disclosed |
| US-12497362-B2 | Cyclopentapyrrole orexin receptor agonists | MERCK SHARP & DOHME LLC (US) | 2025-12-16 | — | — | US | disclosed |
| US-12497362-B2 | Cyclopentapyrrole orexin receptor agonists | MERCK SHARP & DOHME LLC (US) | 2025-12-16 | — | — | US | disclosed |
| EP-0299397-A2 | Peptides with vasorelaxing, natriuretic and diuretic activities, preparation process, agents containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-01-18 | — | — | EP | disclosed |
| US-4725581-A | NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS | ADIR ET COMPAGNIE (FR) | 1988-02-16 | — | — | US | disclosed |
| EP-0231752-A2 | Vasorelaxing, natriuretically and diuretically active peptides, process for their preparation, agents containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-08-12 | — | — | EP | disclosed |